Breakthrough in microRNA research could transform stress management
A recent discovery in microRNA research is changing how scientists understand stress, recovery, and long-term health, potentially leading to new approaches for stress management.
Latest articles in Health
A recent discovery in microRNA research is changing how scientists understand stress, recovery, and long-term health, potentially leading to new approaches for stress management.
An inexpensive amino acid supplement, arginine, has shown potential in reducing toxic amyloid protein buildup in the brain associated with Alzheimer's disease, according to new research.
New research suggests that inflammation, rather than cholesterol, may be the main driver of cardiovascular disease. The findings could lead to new treatments for heart conditions.
Extended deployments at sea are taking a toll on military families' mental health, according to recent studies. Support systems are being developed to address the unique challenges faced by families during long separations.
Three dead in suspected hantavirus outbreak on Atlantic cruise ship MV Hondius. The ship is off Cape Verde as health officials assess disembarkation safety.
A novel drug candidate has demonstrated effectiveness in treating early-stage Alzheimer's disease. The treatment targets specific brain proteins associated with the condition.
Harvard Medical School professor Stuart Orkin has won the 2026 Breakthrough Prize in Life Sciences for his work leading to a CRISPR-based cure for sickle cell disease and beta-thalassemia. The therapy was FDA-approved in 2024.
The latest news on health and medicine, covid, vaccines, global health, mental health, Obamacare, health insurance, Medicare, Medicaid, opioids, cance.
Medical researchers have discovered previously unknown molecular pathways involved in chronic inflammatory conditions, potentially leading to new treatment approaches.
Researchers have discovered a promising new approach that could slow or reverse Alzheimer's disease progression. The treatment targets protein clumps in the brain that are hallmarks of the neurodegenerative condition.